"I prefer to think of it this way - they have advised that the in-human trials will possibly slip by a month or so but have done it discreetly so as not to panic investors - isn't that the sign of good management?"
We are just using a different adverbs, you are using "discreetly", I am using "sneaky". But it all adds up to the same thing. Even shareholders, who have a lot of skin in the game couldn't see this. What implications does this have to option holders (I still have a whole fistful of them)? So yes, information like this is important. As is transparency from the company.
I would like to see an upfront approach from management. They just needed to explain that restrictions prevented the trial to go ahead as planned, so this is how we are moving forward. That's a positive stance. Every share holder and potential share holder understands this, as all of them are also restricted. Hiding information in small print never ends well, as it always comes to light.
Which approach do you think will add value to the share price over the long term? As I said, this is the second announcement that has done the same thing. I hope the trend does not continue.
IHL Price at posting:
5.2¢ Sentiment: Buy Disclosure: Held
